INTRODUCTION
============

Septic pulmonary embolism (SPE) is an uncommon syndrome characterized by embolization of infected thrombi from a primary infectious site into the venous circulation with implantation into pulmonary vasculature resulting in parenchymal infection. The clinical presentation varies from an insidious illness with fever and respiratory symptoms such as cough, shortness of breath, and pleuritic chest pain to an acute sepsis syndrome. In the right clinical context, the diagnosis of SPE is often triggered by a characteristic pattern seen on chest imaging studies with multiple, bilateral peripheral pulmonary nodules often with cavitations.

Historically, SPE was most commonly associated with Lemierre's syndrome \[[@R1]\], post-partum septic pelvic thrombophlebitis \[[@R2],[@R3]\] and right-sided infective endocarditis in IV drug users \[[@R1]\]. Within the last decade, attention has been drawn to changes in the epidemiology, including the importance of infected vascular catheters and implantable devices \[[@R4]\] and more recently septic thrombophlebitis due to contiguous deep soft tissue or bone infection of the extremities \[[@R5]\]. Thus an increasing number of patients present with symptoms related to an extrapulmonary source of infection, different from the classic presentation reported in the older literature \[[@R1]\].

In order to better understand the evolving etiology of SPE we undertook a retrospective analysis of all cases seen at our institution over the past 13 years.

MATERIALS AND METHODS
=====================

The study was conducted at the Hennepin County Medical Center, a 360 bed Level I trauma center and an urban teaching hospital in Minneapolis, Minnesota. After receiving permission from the hospital's office of human subjects research, a computer aided search of the electronic medical record and the imaging database was performed to identify cases of SPE between January 2000 and January 2013. The terms SPE and its variations were utilized for the purpose of the database search. The records were reviewed for each identified patient and the diagnosis of SPE confirmed if the subject met the following pre-specified case definition as described elsewhere in literature \[[@R4],[@R5]\]: characteristic radiologic findings on CT imaging; a clinical illness with systemic infection and concurrent bacteremia; and an identified extrapulmonary source of infection. Resolution of typical radiological lesions with appropriate antibiotic treatment further helped strengthen the diagnosis.

All images were reviewed by a radiologist (GVP) and all patients' electronic medical records were reviewed independently by 2 of the authors (UG and JAB) with further review by a third author (DNW) in questionable cases. Demographic variables obtained included age at diagnosis and gender. Clinical data included: relevant comorbidities, clinical presentation, microbiologic data, cardiac and other imaging, treatment modalities including surgical procedures, duration of hospitalization, duration and type of antibiotic therapy and treatment outcomes.

RESULTS
=======

The study population consisted of 40 patients aged 17-71 years (median age 46 years). There were 29 men and 11 women (Table **[1](#T1){ref-type="table"}**). One patient had two episodes of SPE, one year apart. In 26 of the 41 cases (63%) radiographic features of SPE were detected within 72 hours of presentation.

Presenting symptoms included a febrile illness (85%), pulmonary symptoms, most typically pleuritic chest pain (22%), cough (19%) and dyspnea (15%). Eight patients (19%) presented with septic shock. Thirteen patients (32%) were admitted directly to the medical intensive care unit because of the acuity of their illness, 8 (61%) of whom did not survive the hospitalization (Table **[2](#T2){ref-type="table"}**). Identified comorbidities at the time of admission included IV drug abuse (IVDA) (15/41), end-stage renal disease (10/41), diabetes mellitus (7/41) and immunosuppressive states (3/41). A potential source of infection was identified in all but one patient. These included skin and soft tissue sites (cellulitis 1 case, infected skin ulcers 4 cases, deep subcutaneous abscess 13 cases) predominantly; followed by infective endocarditis, indwelling IV devices, and peripherally infected deep venous thrombosis (Fig. **[1A](#F1){ref-type="fig"}**). Microbiologic studies underscored the importance of *staphylococcus aureus* as the predominant cause (35 cases, 21 due to Methicillin Sensitive *Staphylococcus aureus*- MSSA and 14 Methicillin Resistant - MRSA) (Fig. **[1B](#F1){ref-type="fig"}**). Thirty seven patients had positive blood cultures (Fig. **[1C](#F1){ref-type="fig"}**).

All patients had echocardiograms undertaken, with the exception of one who died within one day of admission. 18 patients (45%) underwent transesophageal echocardiograms. Of the 11 cases of infective endocarditis (IE), 8 involved the tricuspid, 2 the mitral and one the pulmonic valve. 10 of these patients had definite IE according to the modified Li-Duke criteria \[[@R6]\].

All patients, as required by definition, had chest CT imaging and the majority (36/41) also had chest radiographs performed. All had peripheral nodular lesions on the CT, with cavitations in 29/41 (71%) (Table **[3](#T3){ref-type="table"}**). About half (54%) of the patients also had non-nodular infiltrates including some (4/41) with ground glass infiltrates. Twenty one patients (51%) had pleural effusions noted on imaging. All patients received antibiotics guided by results of cultures for a median duration of 6 weeks (range: 3 to 12 weeks). Twelve patients (29%) required a pulmonary procedure, most typically thoracentesis or chest tube placement. All of the drained effusions were characterized as exudative. Ten patients (24%) required source control with local incision and drainage of a peripheral site of infection or IV access removal (2 patients)/revision. Seven patients (17%) required systemic anticoagulation for identified thromboses. Thirty three patients (80%) improved and were discharged from the hospital. Twenty nine patients had follow up imaging documenting complete resolution of the lesions following antibiotic treatment.

DISCUSSION
==========

SPE is an uncommon and serious disorder associated with significant morbidity and mortality. It remains a difficult diagnosis in part because of its varied etiology and clinical presentations. In this study we highlight the broad spectrum of etiologic causes that have changed over time. In one of the largest early studies reported by MacMillan *et al.*\[[@R1]\], 75% of cases of SPE were seen in the setting of right-sided infective endocarditis secondary to IV drug abuse, some with incidental superficial skin abscesses. More recently, Cook *et al.*\[[@R4]\] reported the role of infected IV catheters and devices as a source of SPE. The current series draws attention to the importance of skin, deep soft tissue and bone infections of the extremities as a key source. Infections with contiguous septic thrombophlebitis leading to SPE have been well established in pediatric populations \[[@R3]\] but have only recently been emphasized in adults by Brenes *et al.*\[[@R5]\]. Irrespective of the initial site of infection, there is a common sequence of events that triggers this syndrome (Fig. **[2](#F2){ref-type="fig"}**). An extrapulmonary site of infection can allow extravasation or translocation \[[@R7]\] of an organism, most commonly bacterial, into the systemic venous circulation. Once in the bloodstream, the pathogen can produce damage directly through toxins \[[@R8]\] and indirectly *via*inflammatory mediators \[[@R9]\], which may occasionally promote local thrombosis \[[@R10]\], which serves as an additional nidus for proliferation of the bacteria. Embolization of these thrombi into the pulmonary circulation allows for metastatic parenchymal infection of the lungs, even in the absence of cardiac valvular involvement. Special attention should be given to *Staphylococcus aureus*, which can provoke an intense inflammatory reaction, with direct endothelial damage *via*cytotoxins (e.g. Panton-Valentine leukocidin) and enzymatic mechanisms (e.g. Coagulase), culminating in septic pulmonary emboli, with concomitant septic thrombophlebitis in a minority of the cases \[[@R5]\].

The diagnosis of SPE should be suspected in a febrile bacteremic patient, with an identified extrapulmonary source of infection who develops secondary pulmonary symptoms such as pleuritic chest pain, dyspnea and cough. Although plain chest radiographs are usually obtained in such patients, they are notorious for their low sensitivity \[[@R11]\] with up to 22% being interpreted as normal in our study. However, if the suspicion is high, chest CT scans should be obtained to further evaluate the respiratory symptoms. The diagnosis of septic pulmonary embolism is strongly supported by characteristic findings including multiple bilateral peripheral nodules, often pleural based, with or without cavitary changes \[[@R11],[@R12]\]. These chest CT findings typically lead to cardiac imaging because of the association with right-sided infective endocarditis. The absence of obvious cardiac valvular lesions should prompt careful consideration of other potential sources of infection including IV and other devices as well as thrombophlebitis due to skin and soft tissue infections. Additional imaging including ultrasound and directed CT scanning studies greatly aid in delineating the root cause of infection. Such work-ups may also help differentiate other syndromes with similar imaging characteristics and guide therapy \[[@R13]\].

The identification of a microbiologic etiology with blood, sputum and pleural fluid cultures and when relevant, deep soft tissue, bone and explanted device cultures \[[@R14]\] is critical. The microbiologic diagnosis may be hampered by early initiation of empiric antibiotic therapy \[[@R15]\] and this was the likely explanation of our inability to identify the primary source of infection in one patient.

*Staphylococcus aureus* and MSSA in particular, remains the most likely pathogen as evidenced in our series. This is consistent with the higher frequency of skin and soft tissue infections as the initial extrapulmonary source. The microbiology of SPE may vary due to a number of factors including: the underlying source (*Fusobacterium necrophorum* and anaerobes in Lemierrie's syndrome \[[@R2],[@R4]\]; *Bacteroides* sp in pelvic thrombophlebitis etc.) \[[@R16],[@R17]\]; geography (preponderance of *Klebsiella* in Korea and SE Asia) \[[@R17]\] and the host (non typhoidal *Salmonella* in HIV/ AIDS) \[[@R18]\]. Empiric antibiotic therapy should be promptly started, initially with glycopeptides and in appropriate settings, the addition of broad spectrum antibiotics. Antibiotics can then be modified in the light of culture results and continued for a minimum of 4-6 weeks, guided by the clinical improvement and by results of follow up cultures, inflammatory markers and imaging studies.

The role of thoracic surgical treatment has diminished in recent years, due in part to early diagnosis with improvements in imaging and changes in antibiotic prescribing practice \[[@R19]\]. Pulmonary procedures including thoracentesis and chest tube placement remain important. Most patients (63%) in our series had some procedure performed including the removal of potentially infected devices, surgical drainage of purulent collections and intracardiac valve replacement.

The role of anticoagulation in the treatment of SPE associated with septic thrombophlebitis remains controversial and these agents should not be initiated until acute infective endocarditis has been excluded. This is largely because of concerns for the possibility of bleeding, particularly in the setting of cerebral embolism \[[@R20]\]. Data to guide the use of anticoagulants and antiplatelet therapies in the presence of infective endocarditis remains limited. Thus, recommendations are based largely on observational studies \[[@R21]\] and expert opinion \[[@R22]\]. Given that there are competing risks of thromboembolism and bleeding, therapy should be individualized in every patient with IE. Recent reviews have emphasized the safety of IV heparin in the treatment of septic thrombophlebitis \[[@R23],[@R24]\].

The treatment outcomes in cases of SPE depend on the acuity of the illness on initial presentation. Thirteen (32 %) patients in this series presented acutely ill requiring ICU admission; 8 (20 %) did not survive the hospitalization either due to refractory shock and resultant multi system organ failure or due to grave pulmonary complications including hemorrhage and hemoptysis. Such poor outcome may be related to the late presentation or the presence of severe underlying disease (end stage renal disease, diabetes and immunosuppression) in our patient population.

As evidenced by this relatively large case series, SPE has protean manifestations ranging from an insidious illness with fever and respiratory symptoms to acute sepsis. Physicians should be aware of these clinical presentations as well as the importance of the role of extrapulmonary deep seated infectious sources. Chest CT scans often prompt consideration of this diagnosis and provide the earliest and most easily identifiable indication of systemic embolization of infection. In the absence of ECHO cardiographic or other signs of infective endocarditis further evaluation to identify the infectious source is indicated \[[@R25]\]. Early diagnosis of embolic phenomenon to other organ systems like CNS can greatly impact patient outcome \[[@R22]\]. As with all acute infections, and increasingly so in an era of increased antibiotic resistance, it is essential to obtain prompt blood and other source cultures and to initiate empiric antibiotic therapy, generally directed against *staphylococcus aureus*. Prolonged antibiotic therapy and procedures aimed at amelioration of the infective source are invariably required.

Limitations of this study include its retrospective nature, and the selection bias involved in a single center study. However, our patient population is likely to be more representative of the larger US community population than previous reports from highly specialized centers which may also explain, in part, the differences in the microbiology and outcome characteristics. Another limitation of the study pertains to the fact that transesophageal echocardiogram was not performed in all patients which limits a complete evaluation of endocarditis.

In conclusion, the epidemiology of SPE has broadened over time with an increase in identified extrapulmonary and non-cardiac sources related to contiguous infections. A clearer understanding of the etiology of SPE will help facilitate the diagnosis and management of this potentially fatal condition.
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###### 

Baseline characteristics of 40\# patients diagnosed and treated for SPE between years 2000 and 2013.

  Characteristics                                         No. (%)
  ------------------------------------------------------- ------------
   Age -- median (range) years                            46 (17-71)
    Males                                                 29 (72)
    Females                                               11 (28)
   Relevant co-morbidities\*                              
    IV drug use                                           15 (36)
    End stage renal disease with ongoing dialysis         10 (24)
    Chronic liver disease (cirrhosis, hepatitis C)        8 (19)
    Diabetes mellitus                                     7 (17)
    Alcoholism and non IV drug use                        4 (10)
  Polytrauma                                              3 (7)
    Congestive heart failure                              2 (5)
    Neurological disorders (seizures, stroke, dementia)   2 (5)
    Immunosuppressive states                              
     Post solid organ transplant                          2 (5)
     HIV/AIDS                                             1 (2)
    Postpartum                                            1 (2)
   None                                                   1 (2)
   Presenting signs/symptoms\*                            
    Febrile illness                                       35 (85)
    Respiratory                                           
     Chest pain                                           9 (22)
     Cough                                                8 (19)
     Dyspnea                                              6 (15)
     Hemoptysis                                           4 (10)
    Hypotension/shock                                     8 (19)
    Neurological (altered mentation, seizure, syncope)    6 (15)
    Musculoskeletal pain                                  8 (19)
    Sore throat                                           2 (5)

40 patients with 41 episodes of SPE (1 patient had 2 separate SPE episodes).

Not absolute percentages as multiple patients had more than one co-morbidities and symptoms.

###### 

Management and outcome variables.

  ---------------------------------------------------------------------------------
  Characteristics                       No./Total No. (%) \* Median (Range) Weeks
  ------------------------------------- -------------------------------------------
  Primary admission bed type            

   ICU                                  13/41 (32)

   Telemetry                            13/41 (32)

   General floor                        15/41 (36)

  Antibiotic use                        41/41 (100)

   Duration\*                           6 (3-12)

  Systemic anticoagulant use            9/15 (60)

  Outcome                               

   Discharged with improvement          33/41 (80)

   Death                                8/41 (20)

  Causes of mortality                   

   Cardiovascular (refractory shock)    4/8 (50)

   Respiratory (respiratory failure,\   3/8 (38)
   massive hemoptysis,\                 
   pulmonary hemorrhage)                

   Other (failure to thrive)            1/8 (12)
  ---------------------------------------------------------------------------------

###### 

CT imaging characteristics and findings.

  Characteristics            No. (%) of Patients
  -------------------------- ---------------------
  Technique                  
  Without IV contrast        12 (29)
  With IV contrast           29 (71)
  Location of lesions        
  Central                    4 (10)
  Peripheral                 41 (100)
  Diffuse                    2 (5)
  Types of lesions           
  Nodular                    41 (100)
  Non-nodular                22 (54)
  Ground glass               4 (10)
  Cavitory                   29 (71)
  Pleural effusion           21 (51)
  Number of lesions          
  Solitary                   3 (7)
  2-5                        18 (45)
  6-10                       5 (12)
  \>10                       15 (36)
  Frequency of cavitations   
  None                       12 (29)
  Some                       11 (27)
  All                        18 (44)
